Our consulting services are second to none. Let our team guide you through the intensive processes concerning clinical research, medical device and technology, and regulatory affairs.
IBS Clinical Study – IBgard® and IBSREST™
Targeted delivery of peppermint oil to the small intestine provides significant improvement in the syndrome of symptoms associated with Irritable Bowel Syndrome.
IBgard®, a novel small intestine targeted delivery system of peppermint oil, results in significant improvement in severe and unbearable IBS symptom intensity. Results from the US based, 4-week, randomized, placebo-controlled, multi-center IBSREST™ trial.
24 hour results from a US based, randomized, placebo-controlled, multi-centered trial, to evaluate a novel peppermint oil delivery system. Results from the IBSREST™ trial.
IBgard®, a novel targeted delivery system of peppermint oil, results in significant improvement in the Total IBS Symptom Score and individual IBS symptoms. Results from the US based, 4-week, randomized, placebo controlled, multi-center IBSREST™ trial